Just a little over a week after it suspended a prescription benefit provider for 21 states, the U.S. Centers for Medicare & Medicaid Services has terminated the company’s contract, effective immediately.

The U.S. Centers for Medicare & Medicaid Services (CMS) has suspended the marketing and enrollment activities of a New York-based company for not meeting the prescription drug needs of some of its members in 21 states.